Clinical guidelines recommend screening low-risk women for cervical cancer every three years after age 30, but most primary care clinicians report that they would advise testing for the disease more frequently, according to a new study. Adding a test for human papillomavirus to screening protocols does not increase clinicians' reported adherence to guidelines, but may make them less likely to extend screening intervals.